Effects of Probiotics on Toll‑like Receptor Expression in Ulcerative Colitis Rats Induced by 2,4,6‑trinitro‑benzene Sulfonic Acid

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2017 Mar 6

PMID 28260106

Citations 20

Authors

Ping Yao

Fang Tan

Hongliang Gao

Lei Wang

Tao Yang

Yongbo Cheng

Affiliations

Soon will be listed here.

Abstract

The present study aimed to investigate the regulatory effect of probiotics on the expression of Toll‑like receptors (TLRs) in an ulcerative colitis (UC) rat model, and to determine the role of probiotics in the underlying mechanisms through which UC develops and progresses in rat models. Rats were randomly allocated to one of the four following groups: i) The healthy control, ii) the model, iii) the Golden bifid treatment group, and iv) the TLR4 monoclonal antibody (TLR4mAb) intervention group. The UC rat model was established using 2,4,6‑trinitro‑benzene sulfonic acid. The general status and histological changes of rats were scored using the disease activity index and the histopathological scoring method, respectively. In these rats, the expression of TLR4 and TLR2 was measured using reverse transcription‑quantitative polymerase chain reaction. The expression of TLR4 and TLR2 in the model group was significantly higher than that in the healthy control group. However, when compared with the model rats, those that received either Golden bifid treatment or TLR4mAb intervention exhibited significantly decreased mRNA expression levels of TLR4 and TLR2 (P<0.05). The development of UC is characterized by an abnormal immune response in the intestines. Probiotics alleviated inflammatory reactions in rats with UC. The underlying mechanism of UC may be associated with the expression of TLRs and the subsequent release of inflammatory cytokines.

Citing Articles

Immunomodulatory effects of live and UV-killed natto on inflammatory response in human colorectal adenocarcinoma cell line .

Elkhichi P, Aslanimehr M, Javadi A, Yadegar A Iran J Microbiol. 2024; 16(4):434-442.

PMID: 39267934 PMC: 11389770. DOI: 10.18502/ijm.v16i4.16301.

Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases.

Petrariu O, Czobor Barbu I, Niculescu A, Constantin M, Grigore G, Cristian R Front Microbiol. 2024; 14:1296447.

PMID: 38249451 PMC: 10797027. DOI: 10.3389/fmicb.2023.1296447.

The Anti-Inflammatory Effect of a Probiotic Cocktail in Human Feces Induced-Mouse Model.

Salimi A, Sepehr A, Hejazifar N, Talebi M, Rohani M, Pourshafie M Inflammation. 2023; 46(6):2178-2192.

PMID: 37599322 DOI: 10.1007/s10753-023-01870-x.

The inhibitory effects of live and UV-killed Akkermansia muciniphila and its derivatives on cytotoxicity and inflammatory response induced by Clostridioides difficile RT001 in vitro.

Nasiri G, Azimirad M, Goudarzi H, Amirkamali S, Yadegar A, Ghalavand Z Int Microbiol. 2023; 27(2):393-409.

PMID: 37479958 DOI: 10.1007/s10123-023-00398-2.

The anti-inflammatory effects of minocycline on lipopolysaccharide-induced paw oedema in rats: a histopathological and molecular study.

Shihmani B, Rassouli A, Mehrzad J, Shokrpoor S Inflammopharmacology. 2023; 31(4):1913-1928.

PMID: 37119392 DOI: 10.1007/s10787-023-01236-7.

References

Frolova L, Drastich P, Rossmann P, Klimesova K, Tlaskalova-Hogenova H . Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J Histochem Cytochem. 2007; 56(3):267-74. PMC: 2324181. DOI: 10.1369/jhc.7A7303.2007. View

Schirbel A, Fiocchi C . Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010; 11(5):266-76. DOI: 10.1111/j.1751-2980.2010.00449.x. View

Haller D, Russo M, Sartor R, Jobin C . IKK beta and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteria-induced RelA phosphorylation and NF-kappa B activation in both primary and intestinal epithelial cell lines. J Biol Chem. 2002; 277(41):38168-78. DOI: 10.1074/jbc.M205737200. View

Khor B, Gardet A, Xavier R . Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011; 474(7351):307-17. PMC: 3204665. DOI: 10.1038/nature10209. View

Fromowitz F, Viola M, Chao S, Oravez S, Mishriki Y, Finkel G . ras p21 expression in the progression of breast cancer. Hum Pathol. 1987; 18(12):1268-75. DOI: 10.1016/s0046-8177(87)80412-4. View

Borrello S, Nicolo C, Delogu G, Pandolfi F, Ria F . TLR2: a crossroads between infections and autoimmunity?. Int J Immunopathol Pharmacol. 2011; 24(3):549-56. DOI: 10.1177/039463201102400301. View

Rachmilewitz D, Karmeli F, Shteingart S, Lee J, Takabayashi K, Raz E . Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis. Inflamm Bowel Dis. 2006; 12(5):339-45. DOI: 10.1097/01.MIB.0000217335.30689.77. View

Nagasaki A, Takahashi H, Iinuma M, Uchiyama T, Watanabe S, Koide T . Ulcerative colitis with multidrug-resistant Pseudomonas aeruginosa infection successfully treated with bifidobacterium. Digestion. 2010; 81(3):204-5. DOI: 10.1159/000236042. View

Mardini H, Grigorian A . Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis. Inflamm Bowel Dis. 2014; 20(9):1562-7. DOI: 10.1097/MIB.0000000000000084. View

10.

Canto E, Ricart E, Monfort D, Gonzalez-Juan D, Balanzo J, Rodriguez-Sanchez J . TNF alpha production to TLR2 ligands in active IBD patients. Clin Immunol. 2006; 119(2):156-65. DOI: 10.1016/j.clim.2005.12.005. View

11.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

12.

Roberts-Thomson I, Fon J, Uylaki W, Cummins A, Barry S . Cells, cytokines and inflammatory bowel disease: a clinical perspective. Expert Rev Gastroenterol Hepatol. 2011; 5(6):703-16. DOI: 10.1586/egh.11.74. View

13.

Ostvik A, Granlund A, Torp S, Flatberg A, Beisvag V, Waldum H . Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin Exp Immunol. 2013; 173(3):502-11. PMC: 3949638. DOI: 10.1111/cei.12136. View

14.

Suzuki M, Hisamatsu T, Podolsky D . Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun. 2003; 71(6):3503-11. PMC: 155722. DOI: 10.1128/IAI.71.6.3503-3511.2003. View

15.

Wang L, Li Y, Zhu H, Zhu Z, Ma X . [Influence of bifidobacterium DNA on PKC and NF-kappaB in murine macrophages]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007; 23(1):11-3. View

16.

Sprong R, Schonewille A, van der Meer R . Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota. J Dairy Sci. 2010; 93(4):1364-71. DOI: 10.3168/jds.2009-2397. View

17.

Fort M, Mozaffarian A, Stover A, da Silva Correia J, Johnson D, Crane R . A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol. 2005; 174(10):6416-23. DOI: 10.4049/jimmunol.174.10.6416. View

18.

Servin A . Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28(4):405-40. DOI: 10.1016/j.femsre.2004.01.003. View

19.

Cooper H, Murthy S, Shah R, Sedergran D . Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993; 69(2):238-49. View

20.

Carmen Collado M, Surono I, Meriluoto J, Salminen S . Potential probiotic characteristics of Lactobacillus and Enterococcus strains isolated from traditional dadih fermented milk against pathogen intestinal colonization. J Food Prot. 2007; 70(3):700-5. DOI: 10.4315/0362-028x-70.3.700. View